We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Citing Postmarket Studies, FDA Takes Aim at Drug Shire Plans to Withdraw
Citing Postmarket Studies, FDA Takes Aim at Drug Shire Plans to Withdraw
August 18, 2010
The FDA is taking steps to withdraw a low blood pressure drug that has been on the market for 14 years, saying the drugmaker failed to deliver the necessary postmarket trials. But the drugmaker tells a different story.